S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.01%) $80.07
Gas
(1.60%) $2.67
Gold
(1.07%) $2 443.20
Silver
(4.34%) $32.62
Platinum
(1.30%) $1 104.20
USD/EUR
(-0.07%) $0.919
USD/NOK
(-0.15%) $10.66
USD/GBP
(-0.02%) $0.787
USD/RUB
(0.08%) $91.05

Realtime updates for ALTEOGEN Inc. [196170.KQ]

Exchange: KOSDAQ
Last Updated20 May 2024 @ 00:06

0.79% KRW 191 100

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 00:06):

ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology...

Stats
Today's Volume 952 743
Average Volume 2.00M
Market Cap 10 126.02B
EPS KRW392.40 ( 2024-05-16 )
Next earnings date ( KRW0 ) 2024-08-08
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW373.40 (0.20%)

Volume Correlation

Long: -0.05 (neutral)
Short: -0.42 (neutral)
Signal:(54.872) Neutral

ALTEOGEN Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ALTEOGEN Inc. Correlation - Currency/Commodity

The country flag 0.43
( neutral )
The country flag -0.11
( neutral )
The country flag 0.70
( moderate )
The country flag -0.01
( neutral )
The country flag -0.09
( neutral )
The country flag 0.66
( moderate )

ALTEOGEN Inc. Financials

Annual 2023
Revenue: KRW96.52B
Gross Profit: KRW82.23B (85.19 %)
EPS: KRW-65.27
FY 2023
Revenue: KRW96.52B
Gross Profit: KRW82.23B (85.19 %)
EPS: KRW-65.27
FY 2022
Revenue: KRW28.81B
Gross Profit: KRW9.41B (32.67 %)
EPS: KRW-158.85

Financial Reports:

No articles found.

ALTEOGEN Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

ALTEOGEN Inc.

ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; and ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology. The company has a strategic alliance with Kissei Pharmaceutical to develop Aflibercept that has completed pre-clinical trial; and Cristalia for the development of Trastuzumab, which is in the Phase II clinical trial for the treatment of breast cancer. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators